Latest pulmonary fibrosis Stories
Genetic Variant Associated with MUC5B Gene ID's Major Risk Factor, Points Research in New Direction CULVER CITY, Calif., April 21, 2011/PRNewswire-USNewswire/ -- A new discovery in a deadly lung disease may change the direction of research while uncovering increased risk for many patients and families.
A team led by researchers at National Jewish Health has discovered a new genetic variation that increases the risk of developing pulmonary fibrosis by 7 to 22 times.
Pulmonary Fibrosis Foundation Names Dolly Kervitsky as Vice President of Patient Relations CHICAGO, April 20, 2011 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) has appointed respiratory therapist and certified clinical research coordinator, Dolly Kervitsky, RCP, CCRC, as Vice President of Patient Relations.
Vistancia Roadrunners Car Club Holds Breath of Life Car Show for Pulmonary Fibrosis PEORIA, Ariz., March 18, 2011 /PRNewswire-USNewswire/ -- The Vistancia Roadrunners Car Club is driving an effort to raise awareness and funding for a deadly lung disease that threatens one of their members. Elliot Walsey was diagnosed September 2006 with pulmonary fibrosis (PF), a deadly lung disease that has no FDA approved treatment and no cure.
The American Thoracic Society has released new official clinical guidelines on the diagnosis and management of idiopathic pulmonary fibrosis (IPF).
Guidelines Update 11-Year-Old Consensus Statement for Deadly Lung Disease CULVER CITY, Calif., March 16, 2011 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) applauds the joint statement issued by the American Thoracic Society for the first evidence-based clinical guidelines for the treatment of idiopathic pulmonary fibrosis (IPF).
CPF and PFF Commit to ATS to Fund Grants CULVER CITY, Calif., Feb.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, â€œTGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.â€
Esbriet (Pirfenidone) Passes Hurdle, Way Clear for EU Approval CULVER CITY, Calif., Dec.
Pulmonary Fibrosis Efforts Grow in 2010 CULVER CITY, Calif., Dec. 20, 2010 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) achieved milestones in 2010 in advocacy, research support and awareness of Pulmonary Fibrosis (PF).
- To give a box on the ear to.